1. Inicio
  2. Acciones
  3. Hong-Kong
  4. Hong Kong Stock Exchange
  5. Genscript Biotech Corporation
  6. Noticias
  7. Otros idiomas
    1548   KYG3825B1059

GENSCRIPT BIOTECH CORPORATION

(1548)
  Reporte
Diferido Hong Kong Stock Exchange  -  10:08 12/08/2022
28.35 HKD   -0.35%
08/08GenScript Biotech prevé una pérdida neta de hasta 137 millones de dólares en el primer semestre
MT
07/08Genscript Biotech Corporation ofrece una guía de ganancias para los seis meses que terminan el 30 de junio de 2022
CI
05/08Genscript Biotech Corporation anuncia cambios en la Junta Directiva
CI
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre GENSCRIPT BIOTECH CORPORATION
08/08GenScript Biotech Sees Up to $137 Million H1 Net Loss
07/08Genscript Biotech Corporation Provides Earnings Guidance for the Six Months Ended June ..
05/08Genscript Biotech Corporation Announces Board Changes
01/08Genscript Biotech Unit Completes Follow-On Offering
27/07Genscript Bio's Nasdaq-listed Unit Prices Stock Offering to Raise $350 Million
26/07GenScript to Host 2nd Annual Gene & Cell Engineering Virtual Summit
26/07Genscript Biotech's Nasdaq-listed Unit Plans $250 Million Stock Offering
22/07Genscript Biotech Unit Logs $24 Million in Q2 Sales of Immunotherapy; Shares Slip 3%
08/07GenScript Biotech Unit Terminates Phase 1 Study for Lymphoma Therapy; Shares Down 3%
07/07Genscript Biotech Unit Completes $37 Million Sale of Series B Shares
06/06Genscript Biotech Unit Presents Updated Study Results of Cancer Therapy at US Oncology ..
26/05GenScript USA Enters Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neut..
26/05Genscript Biotech Corporation Signs A Memorandum of Understanding with Singapore Instit..
10/05Genscript Biotech's Nasdaq-listed Unit Promotes Finance VP to CFO; Shares Slip 5%
03/05Chinese Prosecutors Won't File Smuggling Charges Against Genscript Biotech; Shares Slip..
03/05Genscript Biotech Corporation Announces Board Changes
22/04Genscript Biotech Unit Receives $50 Million Milestone Payment from Janssen Biotech
13/04GenScript Debuts Industry's Highest Throughput DNA Synthesis Platform for Commercial DN..
21/03Genscript Biotech Widens Loss on Higher R&D Expenses in 2021
21/03TRANSCRIPT : Genscript Biotech Corporation, 2021 Earnings Call, Mar 21, 2022
20/03Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December..
08/03Genscript Biotech's Nasdaq-Listed Unit Secures Supply Deal for Cancer Drug With Janssen
01/03US FDA Approves Genscript Biotech's Immunotherapy for Myeloma
21/02Genscript Biotech's Nasdaq-Listed Arm Sees up to $397.4 Million Loss in 2021
21/02Baidu, Others Poised to Join Hang Seng Index Amid Reshuffle, Analysts Say
18/02Genscript Biotech Corporation Provides Earnings Guidance for the Year Ended 31 December..
18/02Legend Biotech Expects to Show Adjusted Loss for Full-Year 2021
16/02US FDA Suspends Clinical Trial of Genscript Biotech's Nasdaq-Listed Arm for Lymphoma Tr..
14/02Genscript Biotech Shells Out $50 Million in Milestone Payments to Janssen Biotech; Shar..
11/01Genscript Biotech Awards Restricted Shares to CEO
2021Nasdaq-listed Legend Biotech Raises $345 Million in Share Offering
2021Genscript Biotech Subscribes for $90 Million Shares in Legend Bio's ADS Public Offering
2021GenScript Biotech Corp. Expands to the United Kingdom with New Offices and Logistics Ce..
2021NORTH AMERICAN MORNING BRIEFING : Stocks Seen on Hold as Fed Looms
2021Hong Kong-Listed Chinese Biotech Stocks Slide on U.S. Sanction Fears
2021Nasdaq-listed Legend Biotech Plans $300 Million in Stock Offering; Parent Genscript Sha..
2021Genscript Biotech's Nasdaq-Listed Arm Presents Clinical Trial Data for Investigational ..
2021Partner of Genscript's Nasdaq-Listed Arm Submits New Drug Application for Multiple Myel..
2021GENSCRIPT BIOTECH : Launches Closed-End Double-Stranded DNA Service for CRISPR
2021Genscript Biotech's Nasdaq-listed Unit Widens Loss in Q3; Shares Soar 4%
2021GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR
2021Genscript Launches Closed-End Double-Stranded DNA Service for CRISPR
2021Genscript's Nasdaq-Listed Arm to Present 12 Sponsored Studies at American Society of He..
2021US FDA Extends Approval Target Date for Genscript Biotech's Myeloma Drug; Shares Fall 8..
2021GENSCRIPT BIOTECH : Unit Signs Deal for License Application, Commercial Production of Vacc..
2021GENSCRIPT BIOTECH : Nasdaq-listed Arm to Present Preclinical, Clinical Trial Data of Cance..
2021GENSCRIPT BIOTECH : Bio's Nasdaq-Listed Unit to Hold Inaugural R&D Day Event on Oct. 18
2021GENSCRIPT BIOTECH : H1 Loss Narrows on 38% Revenue Growth
2021GENSCRIPT BIOTECH : Nasdaq-Listed Arm Gets Regulatory OK to Start Phase 1 Clinical Trial o..
2021GENSCRIPT BIOTECH : Unit Issues 300 Million Shares to Hillhouse Capital
2021GENSCRIPT BIOTECH : Reports First Half 2021 Results
2021GENSCRIPT BIOTECH : Reports 2021 Interim Financial Results
2021Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30,..
2021DISCLOSEABLE TRANSACTIONS : Deemed disposal of equity interest in probio cayman
2021Genscript Biotech Corporation Announces Notice of Allowance for U.S. Patent Application
2021GENSCRIPT : to Host Gene & Cell Engineering Virtual Summit
2021GENSCRIPT BIOTECH : Bio's Nasdaq-Listed Unit Files Shelf Registration in US; Shares Jump 5..
2021GENSCRIPT BIOTECH : Unit Sets Up Cellular Therapy Manufacturing Facility in Belgium; Share..
2021Duke-NUS Medical School and GenScript Biotech Corporation Announce Notice of Allowance ..
2021GENSCRIPT BIOTECH : Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Ap..
2021GENSCRIPT BIOTECH : Controlling Shareholder Completes Disposal of Stake
2021GENSCRIPT BIOTECH : Issues 103 Million Shares to Hillhouse Capital; Stocks Slide 3%
2021Hillhouse Capital Management, Ltd. completed the acquisition of 2.99% stake in Genscrip..
2021GENSCRIPT : Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreeme..
2021GENSCRIPT BIOTECH : Grants Share Options, Restricted Shares; Shares Rally 5%
2021Genscript Biotech's Nasdaq-listed Unit Readies to Present Study Results of Myeloma Drug
2021US FDA to Prioritize Review of Genscript Biotech's Myeloma Drug
2021Genscript Biotech Corporation Updates on the Investigation by the Zhenjiang Customs Ant..
2021Genscript Biotech Closes Sale of $300 Milion Worth of Legend Biotech Shares to Hillhous..
2021Hong Kong Stocks End Flat Ahead of Index Review Results; Genscript Biotech Gains 3%
2021Genscript Biotech Unit Gets $15 Million as Marketing Application for Cancer Drug Accept..
2021GENSCRIPT BIOTECH : Nasdaq-listed Unit Widens Loss in Q1 as R&D Expenses Balloon
2021OVERSEAS REGULATORY ANNOUNCEMENT : The entry into a subscription agreement for sale of ord..
2021GENSCRIPT BIOTECH : Issue of new shares under general mandate
2021INSIDE INFORMATION : Disposal of shares by a controlling shareholder
1  2  3Siguiente
Próximo evento sobre GENSCRIPT BIOTECH CORPORATION